Beyond Tumor Size, Toward Meaningful Patient Outcomes-Resisting RECIST.
Medicine
Abstract
This Viewpoint evaluates the present relevance of Response Evaluation Criteria in Solid Tumors (RECIST) as cancer therapeutics have evolved beyond cytotoxic chemotherapy in assessing treatment outcomes.